Keywords: Janssen, Johnson & Johnson, Sirturo, TB, USA, FDA, multi-drug resistant tuberculosis, Bedaquiline

Janssen's TB drug Sirturo gains US FDA approval

Article | 02 January 2013

Print This

The US Food and Drug Administration has granted accelerated approval for US health care major Johnson & Johnson (NYSE: JNJ) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in